Point-of-Care Blood Analyzer — Bayer DCA 2000+ (5031C)

The Bayer DCA 2000+ is a versatile point-of-care analyzer engineered for rapid and reliable quantitative testing in a clinical setting. It provides critical diagnostic information from small sample volumes, making it an efficient tool for patient-side testing and immediate clinical assessment.

Key Measurement Capabilities:

• Hemoglobin A1c (HbA1c): Measures the percent concentration of HbA1c in whole blood, a key indicator for monitoring long-term glycemic control in diabetic patients.
• Microalbumin: Quantifies the concentration of albumin in urine, used for the early detection of kidney disease, a common complication of diabetes.
• Creatinine: Measures creatinine concentration in urine, often used to calculate the albumin-to-creatinine ratio (ACR) for a more accurate assessment of kidney function.

By providing results for these essential tests in minutes, the DCA 2000+ analyzer empowers clinicians to make timely treatment decisions and improve patient management directly in the physician's office or clinic. This instrument is a valuable asset for practices focused on diabetes care and chronic disease management.